Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease

Lancet. 1992 Oct 17;340(8825):930-2. doi: 10.1016/0140-6736(92)92816-x.


Infection of the gastric antrum by Helicobacter pylori is associated with recurrent duodenal ulcer disease but the mechanism of ulcerogenesis is unclear. Since pathways inhibiting gastric secretion are defective in patients with duodenal ulcers, we investigated whether H pylori interferes with the normal gastric inhibition that is mediated by somatostatin. We studied 28 patients with active duodenal ulcers in whom H pylori was eradicated successfully. In 18 patients, we measured the density of antral somatostatin-immunoreactive cells and in a further 10 subjects, the amount of somatostatin mRNA before and after eradication of H pylori was determined. After eradication, the median density of somatostatin-immunoreactive cells increased significantly from 9 (range 3-47) to 19 (6-57) cells per mm muscularis mucosa (p = 0.025). The median somatostatin mRNA/rRNA ratio increased from 50 (25-160) to 95 (40-180) (p = 0.01). The number of gastrin cells and quantity of gastrin mRNA did not change significantly. Our results suggest that in duodenal ulcer disease, gastric secretory function is disinhibited through the suppression of mucosal somatostatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Duodenal Ulcer / metabolism
  • Duodenal Ulcer / microbiology*
  • Duodenal Ulcer / pathology
  • Female
  • Gastric Mucosa / metabolism
  • Gastrins / metabolism*
  • Helicobacter Infections / metabolism*
  • Helicobacter pylori*
  • Humans
  • Male
  • Middle Aged
  • Somatostatin / metabolism*


  • Gastrins
  • Somatostatin